» Articles » PMID: 2166230

A Novel Leupeptin-sensitive Serine Endopeptidase Present in Normal and Malignant Rat Mammary Tissues

Overview
Publisher Springer
Specialty Biochemistry
Date 1990 Apr 18
PMID 2166230
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

N-Methyl-N-nitrosourea (MNU)-induced rat mammary adenocarcinomas contain high levels of a novel leupeptin-sensitive serine endopeptidase. Its properties apparently differ from those of other similar endopeptidases reported to be present in various normal and malignant mammalian tissues. The same leupeptinsensitive serine endopeptidase was also detected in normal rat mammary tissues, but at levels approximately 20 times lower than those in MNU-induced mammary tumors. This enzyme, which is a trypsin-like serine endopeptidase, preferentially hydrolyzes various synthetic endopeptidase substrates at the carboxyl side of an arginyl residue. It has an apparent Mr of approximately 160,000 and a Stokes radius of 49 A, as determined by gel filtration. Its isoelectric points range from 4.5 to 4.8, and it has a pH optimum of approximately 7.0. The enzyme is stable from pH 4.0 to 7.0, but is extremely unstable above pH 7.0. Besides leupeptin, its activity is inhibited by antipain, aprotinin, N alpha-p-tosyl-L-lysine chloromethyl ketone and phenylmethylsulfonyl fluoride, but is not inhibited by soybean trypsin inhibitor. Many other potential inhibitors or activators such as 2-mercaptoethanol, p-hydroxymercuribenzoic acid and EDTA have no effect on its activity. The enzyme is adsorbed to p-aminobenzamidine agarose affinity beads at pH 6.5 and elutes at pH 4.0.

Citing Articles

Separation, purification and N-terminal sequence analysis of a novel leupeptin-sensitive serine endopeptidase present in chemically induced rat mammary tumour.

Eto I, Grubbs C Biochem J. 1992; 283 ( Pt 1):209-16.

PMID: 1314562 PMC: 1131016. DOI: 10.1042/bj2830209.

References
1.
Sueishi K, Nanno S, Okamura T, Inoue S, Tanaka K . Purification and characterization of human kidney plasminogen activator dissimilar to urokinase. Biochim Biophys Acta. 1982; 717(2):327-36. DOI: 10.1016/0304-4165(82)90187-8. View

2.
Booyse F, Scheinbuks J, Radek J, Osikowicz G, Feder S, Quarfoot A . Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells. Thromb Res. 1981; 24(5-6):495-504. DOI: 10.1016/0049-3848(81)90085-2. View

3.
Cool D, Edgell C, Louie G, Zoller M, Brayer G, MacGillivray R . Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa. J Biol Chem. 1985; 260(25):13666-76. View

4.
Koide T, Kato H, Davie E . Isolation and characterization of bovine factor XI (plasma thromboplastin antecedent). Biochemistry. 1977; 16(10):2279-86. DOI: 10.1021/bi00629a037. View

5.
Hashimoto K, Yamanishi Y, Maeyens E, Dabbous M, Kanzaki T . Collagenolytic activities of squamous cell carcinoma of the skin. Cancer Res. 1973; 33(11):2790-801. View